^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BI 765049

    i
    Other names: BI 765049, B7-H6/CD3 T-cell engager, OBT624
    Associations
    News
    Trials
    Company:
    Boehringer Ingelheim, Oxford BioTherap
    Drug class:
    CD3 agonist, B7-H6 inhibitor
    Related drugs:
    Associations
    News
    Trials